Loading clinical trials...
Loading clinical trials...
The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEA...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Washington University School of Medicine
Collaborators
NCT07480265 · Hypertension (HTN), Hyperhomocysteinemia, and more
NCT07444138 · Hypertension, Hypertension (HTN)
NCT07213479 · Hypertension (HTN)
NCT07380022 · IBD, Hypertension (HTN), and more
NCT07357272 · Hypertension (HTN), Sleep Apnea Syndrome, Obstructive
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions